Grey Wolf Therapeutics

Greywolf Therapeutics

Oxford, United Kingdom · Founded 2017 · $115.6M raised

Headquarters
Oxford
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$115.6M
Last Round
$50.0M Series BMay 2024
Rounds
4

About

Greywolf is a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system. Headquartered in Oxford, UK, the company develops oral small molecules now in Phase 1/2 trials. Founded in 2017 by Peter Joyce, former R&D Lead at Vertex Pharmaceuticals, and Tom McCarthy, former President and CEO of Spinifex Pharmaceuticals, Greywolf's mission is to deliver a new class of treatments for people living with cancers and autoimmune disorders.

Summary

Grey Wolf Therapeutics is a Biotech company based in Oxford, United Kingdom, founded in 2017. It has raised $115.6M in total across 4 rounds, most recently a $50.0M Series B round in May 2024. Investors include ICG Life Sciences, Pfizer Ventures and Earlybird Venture Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMay 2024
$50.0M

Sign up to see all 4 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Grey Wolf Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/grey-wolf-therapeutics"><img src="https://indexed.vc/api/badge/company/grey-wolf-therapeutics" alt="Grey Wolf Therapeutics on Indexed.vc" width="260" height="76" /></a>